Ronald Martell, Jasper Therapeutics CEO

Jasper re­ports more da­ta in spon­ta­neous hives from tiny study

Jasper Ther­a­peu­tics con­tin­ued build­ing out the da­ta for a drug de­signed to treat ir­ri­ta­ble skin con­di­tions, though the lat­est re­sults came from a small tri­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.